جست‌وجوی استاد و پژوهشگر

John McGreadyمشاهده پروفایل

استاد آموزشی

• Biostatistics
• Statistical Education
• Statistical Methods
• +۴ مورد دیگر

John McGready, PhD, ScM, is a Teaching Professor in the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health. He is affiliated with multiple centers including the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins Biostatistics Center (JHBC), The Johns Hopkins Institute for Clinical and Translational Research, and the R³ Center for Innovation in Science Education (R3ISE). Dr. McGready earned his PhD from the Johns Hopkins Bloomberg School of Public Health in 2008 and his ScM from Harvard School of Public Health in 1996. Prior to joining Johns Hopkins, he worked as a quantitative policy analyst focusing on criminal justice policy, taught high school math in Washington, D.C., and worked as a healthcare data analyst for Healthcare Investment Analysts. His research interests span biostatistics, statistical education, statistical consulting, statistical methods, and statistical literacy. Dr. McGready is particularly known for his work in statistical education and has developed numerous teaching materials including OpenCourseWare. His research collaborations extend across multiple departments at the Bloomberg School including Health Policy and Management, Epidemiology, International Health, and Population and Family Reproductive Health, as well as with the Johns Hopkins University School of Medicine and Johns Hopkins Healthcare. His publication record shows a diverse range of research interests from clinical applications of biostatistics to educational methods. Recent work spans pulmonary function analysis, diabetes prevention using AI, food security measurement, and growth patterns in genetic conditions like achondroplasia. His work combines rigorous statistical methodology with practical applications in public health and clinical medicine. Dr. McGready has received numerous teaching awards throughout his career: Multiple Golden Apple Teaching Awards (2001, 2004, 2008, 2012, 2016, 2020, 2024) Ernest Lyman Stebbins Medal (2021) ASPH/Pfizer Early Career Award for Teaching Excellence (2010) Outstanding Teacher Award from the American Statistical Association (2010) Excellence in Online Education Awards (2001, 2005) As the primary instructor for 'Statistical Reasoning in Public Health I and II' (taught both on campus and online) and 'Statistical Methods in Public Health III,' Dr. McGready has significantly impacted statistical education. He is also the co-creator and instructor of intensive data analysis workshops offered in the School's Summer Institute of Epidemiology and Biostatistics. His research collaborations span numerous public health domains, with particular emphasis on clinical applications of biostatistical methods.

• Pulmonology
• Respiratory Medicine
• Internal Medicine
• +۲ مورد دیگر

Maria Jose Soler Sempere serves as a Part-time Lecturer in the Department of Clinical Medicine at Miguel Hernandez University of Elche, specializing in Pulmonary Diseases within the Health Sciences category. Her teaching portfolio encompasses laboratory instruction for Integrated Workshops III, Internal Medicine Rotations I/II, and Respiratory System Pathology in the Medicine Bachelor's program, alongside General Pathology for Podiatry students. Her research concentrates on clinical pulmonology with emphases on COPD pathophysiology, asthma management complexities, pleural disease diagnostics, and pandemic-related respiratory impacts. Key investigations explore treatment adherence barriers including nocebo effects in inhaler therapy, novel biomarkers for effusion differentiation, and microplastic exposure from tobacco combustion. Publication trends reveal consistent clinical focus with evolving pandemic-era priorities: pre-2020 work centered on tuberculosis diagnostics and pleural biomarkers (C-reactive protein, cystatin C), while recent studies analyze COPD/asthma interactions with SARS-CoV-2, sarcopenia in exacerbations, and home management of pleural catheters. Her methodology favors observational clinical studies with biochemical and epidemiological analyses.

• Pediatric Physical Therapy
• Neurological Rehabilitation
• Orthopedic Rehabilitation
• +۳ مورد دیگر

Dr. Lecturer Yusuf TOPAL is a full-time academic at Ahi Evran University, School of Physical Therapy and Rehabilitation , Department of Physical Therapy and Rehabilitation. He holds a PhD in Physical Therapy and Rehabilitation from Hacettepe University (2018–2023) and a Master’s in the same field (2016–2018). Education: PhD: Physical Therapy and Rehabilitation, Hacettepe University (2018–2023) MSc: Physical Therapy and Rehabilitation, Hacettepe University (2016–2018) BSc: Physiotherapy and Rehabilitation, Dumlupınar University (2003–2007) His research focuses on pediatric physical therapy , particularly developmental outcomes in preterm infants and those born to mothers with gestational diabetes or pre-eclampsia . He investigates spatiotemporal gait characteristics , dynamic balance , and lower extremity muscle strength in both pediatric and orthopedic populations. Recent publications highlight collaborations on knee osteoarthritis rehabilitation , hip arthroplasty recovery , and geriatric rehabilitation challenges. His work has been cited in SCI/SSCI/ESCI journals and international conferences like the European Academy of Childhood Disability (2020). He collaborates extensively with researchers such as Gizem İrem Kınıklı (Karabük University), Akmer Mutlu (Hacettepe University), and Bilge Nur Yardımcı Lokmanoğlu (Hacettepe University), reflecting interdisciplinary efforts in pediatric and orthopedic rehabilitation .

• High Altitude Physiology
• Cerebrovascular Hemodynamics
• Hemorheology
• +۳ مورد دیگر

Travis Gibbons is an Assistant Professor in the Department of Biological Sciences at Northern Arizona University. His research focuses on high-altitude physiology, cerebrovascular hemodynamics, and hemorheology. He has published extensively on topics such as respiratory acidosis, platelet loss during exercise at altitude, and CO 2 -mediated cerebral metabolism. Academic Rank: Assistant Professor Department: Biological Sciences University: Northern Arizona University His work combines physiological research with pharmacological interventions , particularly examining the effects of pentoxifylline on hemorheology and cerebral blood flow. Recent studies investigate: Neurovascular coupling during hypoxia Immunometabolic responses to fasting and exercise Platelet dynamics in high-altitude environments Hypercapnia's impact on cerebral oxidative metabolism The trends in his 2024-2025 publications emphasize altitude acclimatization , vascular reactivity , and exercise-induced physiological changes . His cerebrovascular research often employs Doppler imaging and metabolic profiling . As of 2025, no scientific awards are mentioned in the provided data.

• Thrombosis
• Haematology
• Cardiovascular Medicine
• +۵ مورد دیگر

Professor Denise Jackson is a faculty member in the Department of Health and Biomedical Sciences at RMIT University, Bundoora West campus. She serves as the Head of the Thrombosis and Vascular Biology laboratory and holds an honorary fellowship from the National Health and Medical Research Council (NHMRC). Her research focuses on thrombosis mechanisms, platelet biology, and immunoreceptor roles in infection and immunity. She coordinates courses such as MEDS1142 Medical Informatics, BUSM3220 Medical Laboratory Quality Systems, and ONPS2153 Medical Informatics and Laboratory Management. Research Interests: Professor Jackson’s work spans thrombosis, platelet function, mouse models of thrombus formation, and the molecular mechanisms of immunoreceptors in pathogens. Her team investigates tetraspanins’ role in blood clot regulation and signaling pathways in platelets. Key projects include studying tyrosine kinase inhibitors’ effects on haemostasis and exploring immunoreceptor crystal structures for drug design. Professional Involvement: She reviews grants for NHMRC, National Heart Foundation, and international bodies like the Wellcome Trust and NSF. She also serves as a reviewer for journals including Nature and Blood . Student Supervision: Principal supervisor of 12 Honours, 3 Masters, and 4 PhD students. Labs/Teams: Leads the Thrombosis and Vascular Biology lab, collaborating on drug development and thrombosis prevention strategies.

Andrew J. Wooمشاهده پروفایل

پژوهشگر ارشد

• Transcriptional gene regulation
• Stem cells and cancer
• Haematopoiesis and blood disorders
• +۵ مورد دیگر

Dr. Andrew J. Woo is a Research Fellow at The University of Western Australia Medical School and the UWA Centre for Medical Research, affiliated with the Harry Perkins Institute of Medical Research. His research focuses on transcriptional gene regulation in stem/progenitor cells of blood and epithelial cancer stem cells. Dr. Woo completed his Bachelor of Science with Honours and PhD in Biochemistry at The University of Western Australia in 2004. He then pursued postdoctoral training under Dr. Alan B. Cantor at Children's Hospital Boston/Dana-Farber Cancer Institute at Harvard Medical School. He returned to Perth in 2012 with a fellowship from the Royal Perth Hospital Medical Research Foundation. Dr. Woo's research interests include understanding transcriptional gene regulatory mechanisms in stem/progenitor cells of blood and epithelial cancer stem cells. With Dr. Peter Leedman at the Harry Perkins Institute of Medical Research, he investigates the role of small non-coding RNA processing complexes in epithelial cancer onset and metastasis. His laboratory employs various techniques including protein-protein interaction identification via proteomics, protein-DNA interaction mapping, transcriptomics, functional genomics, and transgenic mouse models. His recent publications demonstrate a strong focus on cancer research, particularly breast cancer and hepatocellular carcinoma, with significant contributions to understanding transcription factors, oncogenes, and signaling pathways. His work often involves collaboration with other researchers at the Harry Perkins Institute and beyond. Dr. Woo has received the NHMRC project grant near-miss merit award in 2016 and has secured multiple research grants from organizations including Cancer Council of Western Australia and the Medical Research Foundation WA. Dr. Woo has been actively involved in research funding, serving as Chief Investigator on multiple grants since 2012. He also holds an external position as Lecturer and Unit Coordinator at Edith Cowan University from July 2018 to July 2043. His research is conducted within the UWA Centre for Medical Research, which is affiliated with the Harry Perkins Institute of Medical Research, a leading medical research facility in Western Australia.

Drew Adamsمشاهده پروفایل

دانشیار

• Chemical Biology
• Drug Discovery
• Neurodegenerative Diseases
• +۳ مورد دیگر

Drew Adams, PhD, is an Associate Professor in the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine. He leads the Adams Lab, which focuses on chemical biology approaches to identify drug targets and small molecules for neurodegenerative diseases. His work includes collaborations on remyelination therapies and cancer biology, leveraging high-throughput screening and synthetic chemistry. He directs the Small-Molecule Drug Development Core, a facility enabling chemical library screening. Education: B.A. in Biochemistry from Swarthmore College (Highest Honors), PhD in Organic Chemistry from Harvard University (under David A. Evans), postdoc at the Broad Institute with Stuart L. Schreiber. Research: Specializes in small-molecule modulation of cellular processes, particularly sterol signaling in oligodendrocyte differentiation. Key contributions include identifying imidazole antifungals as remyelination enhancers and founding Convelo Therapeutics for myelin repair therapies. Grants/Awards: NIH R01 (2021), Falk Research Trust Grant (2020), 2019 Folch Pi Prize, and the Thomas F. Peterson, Jr. Professorship (2018). Labs/Teams: Adams Lab collaborates with Prof. Paul J. Tesar (CWRU) and Prof. Robert H. Miller (GWU) on remyelination mechanisms. Recent work explores sterol landscape modulation and CYP51 inhibition.

• Bioengineering
• Systems Glycobiology
• Thrombosis & Hemostasis
• +۳ مورد دیگر

Sriram Neelamegham is the UB Distinguished Professor of Chemical & Biological Engineering, Biomedical Engineering, and Medicine at the University at Buffalo, SUNY. His research focuses on applying engineering principles to study molecular mechanisms of blood cell interactions in diseases such as inflammation, thrombosis, and cancer. He leads the Bioengineering Laboratory within the School of Engineering and Applied Sciences. Education: PhD in Chemical/Biomedical Engineering, Rice University, 1996 B.Tech in Chemical Engineering, Indian Institute of Technology Delhi, 1991 Research Interests: Systems Glycobiology: Investigating glycan biosynthesis and its role in disease Leukocyte and Platelet Adhesion Dynamics under Fluid Flow Von Willebrand Factor (VWF) Structure-Function Relationships Engineering Glycoengineered Therapeutics and Diagnostic Tools Key Contributions: Developed computational models and experimental tools for glycosylation pathway analysis Discovered mechanisms of VWF conformational changes under shear stress Pioneered glycoengineering strategies for stem cell targeting Awards & Recognition: NIH Independent Scientist Award (2015) SUNY Chancellor's Award for Excellence (2015) AIMBE Fellow (2012) and BMES Fellow (2019) 2018 Schoellkopf Medal (ACS) Lab Activities: Recruitment of postdocs, full-time, and part-time research technicians Development of glycan-engineered technologies for drug delivery and diagnostics Collaborations with biomedical industries and academic institutions

• Structural Health Monitoring (SHM)
• Smart / self-sensing cementitious composites
• Bridge engineering and life-cycle assessment
• +۶ مورد دیگر

Filippo Ubertini is Professor of Civil and Environmental Engineering at the University of Perugia, Italy, where he coordinates the International Doctoral Programme in Civil & Environmental Engineering and represents the University inside the FABRE national bridge-research consortium. He leads the Structural Health Monitoring Laboratory ( SHM-Lab ) and is the primary contact for assignments linked to smart-infrastructure research. Education: While explicit degrees are not listed in the supplied text, his role as programme coordinator and full professor implies completion of a PhD and habilitation in Civil Engineering. Research focus: Ubertini’s work sits at the intersection of smart materials and data-driven infrastructure management . He develops self-sensing cementitious composites doped with carbon micro-fibers or graphene nano-platelets that can measure strain, cracking and moisture in real time, turning whole bridges and buildings into distributed sensors. Complementary research threads include low-cost acquisition electronics, UAV & InSAR remote sensing, Bayesian & adversarial machine-learning algorithms for damage detection, digital twins and life-cycle cost analysis of bridge networks. Publication trends (2024-2025): Roughly 30 peer-reviewed items per year concentrate on (i) AI-enhanced operational modal analysis and transfer-learning damage classification across bridge populations, (ii) experimental characterisation of 3D-printed and cast self-sensing concrete, (iii) full-scale validation on curved box-girder, masonry and railway bridges, and (iv) integration of satellite radar data with numerical collapse simulations to predict residual service life of landslide-affected viaducts. Scientific awards & recognition: No specific prizes or fellowships are mentioned in the provided text. Doctoral supervision & grants: The text does not enumerate individual students or funded projects; however, his coordination of an international PhD programme and numerous experimental campaigns imply sizeable supervisory and funding responsibilities. Laboratory & team: Ubertini heads the SHM-Lab at UniPg, maintaining facilities for material mixing, 3D concrete printing, electrical impedance tomography, UAV photogrammetry, and large-scale structural testing, while collaborating with the European FABRE consortium and multiple EU projects.

Alan Daughertyمشاهده پروفایل

استاد

• Molecular mechanisms of vascular diseases
• Atherosclerosis
• Aortic aneurysms
• +۴ مورد دیگر

Alan Daugherty, PhD, DSc, FAHA, is a distinguished Professor and Associate Vice President for Research at the University of Kentucky . He serves as Chair of the Department of Physiology and Director of the Saha Cardiovascular Research Center . Additionally, he holds the Gill Foundation Chair in Preventive Cardiology and is Editor-in-Chief of ATVB . Education: Sunderland Polytechnic, UK - B.Sc. (Hons) in Pharmacology (1978) University of Bath, UK - Ph.D. in Pharmacology (1982) University of Bath, UK - Fellow in Cardiology Physiology (1981-1982) Washington University, St. Louis, MO - Fellow in Atherosclerosis (1982-1985) University of Bath, UK - D.Sc. in Pharmacology (2002) Research Focus: Dr. Daugherty's laboratory investigates the molecular mechanisms of human vascular diseases , with particular emphasis on atherosclerosis and aortic aneurysms . His research has evolved from studying lipoprotein modifications and immune responses to focusing on the renin-angiotensin system in vascular pathology. The lab's pioneering work demonstrated that angiotensin II infusion significantly promotes atherosclerosis and aortic aneurysms in hypercholesterolemic mice. Current research examines several components of the renin-angiotensin system including angiotensinogen, renin, angiotensin-converting enzyme, and angiotensin II receptors. The lab employs innovative approaches including conditional cell-specific deficient mice, adeno-associated virus vectors, and antisense oligonucleotides to explore molecular mechanisms and potential therapeutic targets. Research Impact: Dr. Daugherty's translational research has led to significant clinical applications. A 2008 Journal of Clinical Investigation study initiated a clinical trial (AQUARIUS) investigating renin inhibition effects on coronary atherosclerosis progression. Ongoing studies on angiotensinogen inhibition have shown promise in preventing hypertension, atherosclerosis, and obesity, with a human antisense oligonucleotide targeting angiotensinogen awaiting clinical trial approval. Scientific Contributions: With over 380 publications and 25,000+ citations , Dr. Daugherty is a leading figure in cardiovascular research. His extensive publication record spans high-impact journals, focusing on vascular disease mechanisms, therapeutic targets, and translational applications. Leadership and Affiliations: In addition to his primary roles, Dr. Daugherty serves as a mentor in the MD/PhD Program , is core faculty in the CVRC , and is part of the Nutritional Sciences Graduate Faculty . His leadership positions reflect his significant contributions to cardiovascular research and education at the University of Kentucky.

Xiaowei Wangمشاهده پروفایل

استاد

• Molecular Imaging
• Nanotherapeutics
• Cardiovascular Disease
• +۳ مورد دیگر

Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.

Robert N. Benمشاهده پروفایل

استاد

• Organic Chemistry
• Bioorganic Chemistry
• Carbohydrate Chemistry
• +۵ مورد دیگر

Robert N. Ben is a Full Professor in the Department of Chemistry and Biomolecular Sciences at the University of Ottawa. His research focuses on organic and bioorganic chemistry, particularly the development of small-molecule ice recrystallization inhibitors (IRIs) for improving cryopreservation techniques. These inhibitors enhance the viability of cells, tissues, and biological systems during freezing and thawing processes, with applications in regenerative medicine, stem cell therapy, and biomedical engineering. He holds a B.Sc. from Laurentian University (1990) and a Ph.D. from the University of Ottawa (1994). His work bridges synthetic chemistry and biological applications, aiming to design cryoprotectants with enhanced stability and activity for medical and industrial uses. Key research areas include asymmetric synthesis of bioactive compounds, carbohydrate chemistry, and glycoprotein design. Ben’s lab investigates the structure-activity relationships of IRIs, their mechanisms of action, and their utility in preserving diverse biological materials, including red blood cells, stem cells, and tissues. His contributions have advanced understanding of how small molecules mitigate ice crystal growth, reducing cryopreservation damage in cellular therapies and organ preservation. Despite no listed awards, his prolific research output (over 50 publications from 2013–2024) highlights his leadership in cryopreservation science. He advises students in synthetic and bioorganic chemistry but no specific advisees are named in the provided texts. Current projects emphasize translating IRI-based technologies into clinical applications, such as improving platelet and cord blood storage.

• Health Care Management
• Operations Research
• Patient Scheduling
• +۵ مورد دیگر

Professor Patrick Jonathan is a Full Professor at the Telfer School of Management, University of Ottawa. His research focuses on applying operations research methods to healthcare management challenges, particularly in patient scheduling, capacity planning, and disaster response logistics. He holds a B.A.Sc. from McMaster University, M.Sc. and Ph.D. from the University of British Columbia (UBC). Key research areas include healthcare system efficiency, stochastic optimization, approximate dynamic programming, and resource allocation in emergency and long-term care settings. He has contributed to projects like optimizing inpatient unit staffing during pandemics and developing robust logistics models for disaster relief operations. Education: B.A.Sc. (McMaster), M.Sc. (UBC), Ph.D. (UBC) Affiliations: INFORMS, CORS, Centre for Health Care Management (UBC) Recent work emphasizes pandemic-related healthcare operations, including staff scheduling under crisis conditions and elective patient admission strategies during the COVID-19 pandemic. His research also addresses dynamic home care routing and multi-priority patient scheduling policies. He has secured over $2.3 million in research funding through grants from NSERC, MITACS, and the National Research Council. Notable projects include the 'Resilience and Adaptation to Climatic Extreme (RACE) Wildfires' initiative and 'Stochasticity in Approximate Dynamic Programming.' Labs/Teams: Collaborates with interdisciplinary teams on healthcare logistics and emergency department optimization projects.

Andreia Marina Ionescuمشاهده پروفایل

دانشیار

• Developmental Biology
• Skeletal Stem Cell Research
• Osteoarthritis
• +۳ مورد دیگر

Dr. Andreia Marina Ionescu serves as Associate Professor of Biology and Principal Investigator at Northeastern University since July 2020, leading research in skeletal development and regenerative medicine. Education: PhD, University of Rochester (NY) Postdoctoral Fellowship, Harvard Medical School Research Interests: Her lab pioneers investigations into growth plate stem cell hierarchies, FoxA2+ long-term skeletal stem cells (LTSSCs), and osteoarthritis mechanisms. Key focuses include: Transcriptional regulation of chondrocyte differentiation Cartilage regeneration via stem cell populations Nanoparticle-based gene delivery for OA treatment PTHrP signaling in skeletal growth Publication Trends: Recent work (2022-2024) demonstrates integration of single-cell transcriptomics with functional studies to map skeletal stem cell lineages, revealing FoxA2+ LTSSCs as critical regeneration mediators. Parallel efforts develop charge-reversed exosomes for targeted cartilage therapy, bridging developmental biology and translational orthopedics. Scientific Awards: NSF CAREER Award (2024) Advising and Grants: Mentors four graduate students, twelve undergraduate researchers, and two senior scientists. Lab operations are supported by NSF CAREER funding and institutional resources for skeletal biology research. Lab and Team: The Ionescu lab integrates wet-lab biologists (Dr. Muruganandan Shanmugam, Dr. Yu Zhou) with computational expertise (bioinformatician Dr. Yu Zhou) to address skeletal regeneration challenges through molecular, cellular, and tissue-level approaches.

Barbara Wollenbergمشاهده پروفایل

استاد

• Immunology
• Oncology
• Cancer Biology
• +۳ مورد دیگر

Prof. Barbara Wollenberg is a Professor of Otorhinolaryngology at the Technical University of Munich (TUM), leading the Chair of Otorhinolaryngology within the TUM School of Medicine and Health. She specializes in translational research on immunological interactions in head and neck cancer, focusing on biomarker discovery and tumor immune evasion mechanisms. Her work integrates molecular approaches with clinical trials, particularly in immunotherapy. She holds a medical degree from Saarland University and Ludwig-Maximilians-University Munich (LMU), with a doctorate in Immunology and habilitation from LMU. She completed residencies in ENT and additional qualifications in allergology and skull base surgery. Notably, she received a Heisenberg Fellowship from DFG (2001) and joined TUM in 2019 after a tenure at the University of Lübeck. Her research emphasizes biomarkers, tumor-immune dynamics, and immunotherapies for head and neck cancers. Key awards include the Acta Prize (2019), Georg Heberer Prize (2004), and Monika Kutzner Prize (2001). Her publications span immunology, oncology, and translational medicine, with recent work exploring PD-1 inhibitors, tumor microenvironments, and novel therapeutic strategies.